The proliferation of enhancement technologies and pharmacological agents has perpetuated the view of American doctors and patients of medical care as a market commodity driven by what consumers want and are willing to pay for.
Despite their added benefit in assisting physicians with clinical decision making, statistical prediction rules have not been widely used since their introduction in 1954.
Health care professionals have a responsibility to educate patients about public screening programs and ensure that subsequent follow-up is done after the screening is completed.